Apellis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. 

CEO
Cedric Francois
CEOCedric Francois
Employees
706
Employees706
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2009
Founded2009
Employees
706
Employees706

APLS Key Statistics

Market cap
6.09B
Market cap6.09B
Price-Earnings ratio
-10.70
Price-Earnings ratio-10.70
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$51.49
High today$51.49
Low today
$48.71
Low today$48.71
Open price
$50.00
Open price$50.00
Volume
401.28K
Volume401.28K
52 Week high
$94.75
52 Week high$94.75
52 Week low
$19.83
52 Week low$19.83

Analyst ratings

82%

of 17 ratings
Buy
82.4%
Hold
17.6%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.